Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance (Q2803513)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance |
scientific article; zbMATH DE number 6577603
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance |
scientific article; zbMATH DE number 6577603 |
Statements
Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance (English)
0 references
4 May 2016
0 references
exact sequential analysis
0 references
expected time to signal
0 references
post-market safety surveillance
0 references
uniformly better sequential design
0 references
0.8705925345420837
0 references
0.845562219619751
0 references
0.7792961001396179
0 references
0.7706066966056824
0 references
0.7256628274917603
0 references
